AVITA MEDICAL INC (RCEL) Stock Analyst Earnings Estimates
NASDAQ:RCEL - Nasdaq - US05380C1027 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 34.42M 17.76% | 50.143M 45.68% | 64.251M 28.14% | 100.98M 57.16% | 138.03M 36.69% | 183.78M 33.14% | 282.71M 53.83% | 351.13M 24.20% | 400.85M 14.16% | 474.52M 18.38% | 577.48M 21.70% | |
| EBITDA YoY % growth | -26.56M -3.79% | -41.715M -57.06% | -54.873M -31.54% | -23.432M 57.30% | -7.83M 66.58% | 3.314M 142.33% | 35.364M 967.11% | 41.683M 17.87% | 47.9M 14.91% | 53.506M 11.70% | 59.11M 10.47% | |
| EBIT YoY % growth | -27.13M -3.12% | -42.347M -56.09% | -55.999M -32.24% | -22.591M 59.66% | -9.387M 58.45% | 70.555M 851.64% | 123.05M 74.40% | 162.65M 32.18% | 239.26M 47.10% | 318.3M 33.04% | 408.07M 28.20% | |
| Operating Margin | -78.82% | -84.45% | -87.16% | -22.37% | -6.80% | 38.39% | 43.53% | 46.32% | 59.69% | 67.08% | 70.66% | |
| EPS YoY % growth | -1.07 8.55% | -1.40 -30.84% | -2.39 -70.71% | -0.70 70.82% | -0.18 74.73% | 0.07 137.62% | 4.83 7,182.92% | 6.15 27.36% | 6.98 13.55% | 8.85 26.79% | 11.45 29.28% |
All data in USD
| Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.25 57.84% | -0.13 79.02% | -0.01 97.10% | -0.21 59.58% | -0.06 77.82% | 0.04 127.45% | 0.00 73.36% |
| Revenue Q2Q % growth | 23.061M 51.77% | 26.803M 37.13% | 32.173M 74.80% | 24.888M 34.43% | 30.056M 30.33% | 33.898M 26.47% | 34.646M 7.69% |
| EBITDA Q2Q % growth | -5.814M 61.36% | -3.468M 73.15% | -2.856M 67.74% | -6.63M 39.69% | N/A | N/A | -3.468M -21.43% |
| EBIT Q2Q % growth | -5.592M 63.81% | -2.713M 80.10% | -224.4K 97.75% | -6.477M 43.75% | -2.481M 55.63% | -537.54K 80.19% | 335.07K 249.32% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | -0.53 27.40% | -0.39 | -0.14 | -34.96% |
| Q4 2024 Q2Q % growth | -0.44 -57.14% | -0.44 | 0.00 | 0.41% |
| Q3 2024 Q2Q % growth | -0.62 -82.35% | -0.45 | -0.17 | -39.31% |
| Q2 2024 Q2Q % growth | -0.60 -46.34% | -0.53 | -0.07 | -13.56% |
| Q1 2024 Q2Q % growth | -0.73 -97.30% | -0.48 | -0.25 | -51.24% |
| Q4 2023 Q2Q % growth | -0.28 -27.27% | -0.38 | 0.10 | 26.68% |
| Q3 2023 Q2Q % growth | -0.34 -54.55% | -0.45 | 0.11 | 24.92% |
| Q2 2023 Q2Q % growth | -0.41 -64.00% | -0.33 | -0.08 | -23.91% |
| Q1 2023 Q2Q % growth | -0.37 2.63% | -0.26 | -0.11 | -44.52% |
| Q4 2022 Q2Q % growth | -0.22 -29.41% | -0.30 | 0.08 | 26.20% |
| Q3 2022 Q2Q % growth | -0.22 15.38% | -0.35 | 0.13 | 36.47% |
| Q2 2022 Q2Q % growth | -0.25 3.85% | -0.40 | 0.15 | 37.15% |
| Q1 2022 Q2Q % growth | -0.38 20.83% | -0.39 | 0.01 | 1.96% |
| Q4 2021 Q2Q % growth | -0.17 71.67% | -0.40 | 0.23 | 57.54% |
| Q3 2021 Q2Q % growth | -0.26 63.38% | -0.39 | 0.13 | 32.92% |
| Q2 2021 Q2Q % growth | -0.26 56.67% | -0.29 | 0.03 | 11.34% |
| Q1 2021 Q2Q % growth | -0.48 32.39% | -0.31 | -0.17 | -55.57% |
| Q4 2020 Q2Q % growth | -0.60 | -0.44 | -0.16 | -35.23% |
| Q3 2020 Q2Q % growth | -0.71 | -0.39 | -0.32 | -82.82% |
| Q2 2020 Q2Q % growth | -0.60 | -0.25 | -0.35 | -140.10% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | 18.514M 66.73% | 21.565M | -3.051M | -14.15% |
| Q4 2024 Q2Q % growth | 18.406M 29.67% | 21.464M | -3.058M | -14.25% |
| Q3 2024 Q2Q % growth | 19.546M 43.25% | 19.814M | -268K | -1.35% |
| Q2 2024 Q2Q % growth | 15.195M 29.29% | 15.028M | 167K | 1.11% |
| Q1 2024 Q2Q % growth | 11.104M 5.25% | 11.268M | -164K | -1.46% |
| Q4 2023 Q2Q % growth | 14.195M 50.05% | 14.79M | -595K | -4.02% |
| Q3 2023 Q2Q % growth | 13.645M 50.11% | 13.635M | 10K | 0.07% |
| Q2 2023 Q2Q % growth | 11.753M 40.92% | 11.547M | 206K | 1.78% |
| Q1 2023 Q2Q % growth | 10.55M 39.92% | 10.538M | 12K | 0.11% |
| Q4 2022 Q2Q % growth | 9.46M 36.31% | 8.849M | 611K | 6.90% |
| Q3 2022 Q2Q % growth | 9.09M 29.49% | 7.173M | 1.917M | 26.73% |
| Q2 2022 Q2Q % growth | 8.34M -19.03% | 7.293M | 1.047M | 14.36% |
| Q1 2022 Q2Q % growth | 7.54M -14.03% | 6.913M | 627K | 9.07% |
| Q4 2021 Q2Q % growth | 6.94M 36.08% | 7.14M | -200K | -2.80% |
| Q3 2021 Q2Q % growth | 7.02M 38.74% | 6.881M | 139.335K | 2.03% |
| Q2 2021 Q2Q % growth | 10.3M 52.01% | 8.043M | 2.257M | 28.06% |
| Q1 2021 Q2Q % growth | 8.77M 76.74% | 6.883M | 1.887M | 27.42% |
| Q4 2020 Q2Q % growth | 5.1M | 5.712M | -612K | -10.71% |
| Q3 2020 Q2Q % growth | 5.06M | 4.998M | 62K | 1.24% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 15.93% | -0.49% | -3.58% |
| Revenue | 0% | -3.76% | 0% | -3.18% |